<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>14917</id><no>NEOSURG-IIT-NCT06449313</no><status>Open</status><title>A PHASE II SINGLE-ARM STUDY OF NEOADJUVANT CHEMO-IMMUNOTHERAPY AND SURGICAL RESECTION IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER WITH CONTRALATERAL MEDIASTINAL LYMPH NODE INVOLVEMENT (NEO-SURG)</title><secondary_protocol_no>R2810-ONC-2427; STUDY00007668</secondary_protocol_no><nct_id>NCT06449313</nct_id><sponsor_type>Industrial; Institutional</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><scope>Local</scope><disease_site>Lung</disease_site><PI>Reuss, Joshua</PI><institution>Lombardi Comprehensive Cancer Center : Matt Hayhurst; University of Virginia; Washington University School of Medicine</institution><eligibility_file id="67681">Eligibility Checklist_NeoSurg 3.0_8.20.26.docx</eligibility_file><oncology_group>Thoracic/CNS/H&amp;N/Thyroid<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>16691</contact_id><item_description>Matt Hayhurst</item_description><js_safe_str>Matt Hayhurst</js_safe_str><email>mh2340@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>